VBI Vaccines Inc. (VBIV) — Financial statements
Income statement, balance sheet, and cash flow for VBI Vaccines Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 9↑702.4% | 1↑71.5% | 0.63↓40.5% | 1↓52.2% | 2 | |
| Cost of Revenue | 14↑28.6% | 11↑4.7% | 11↑17.5% | 9↑16.0% | 8 | |
| Gross Profit | -6↑43.0% | -10↓0.5% | -10↓25.1% | -8↓42.7% | -6 | |
| Operating Expenses | ||||||
| R&D Expenses | 9↓39.7% | 16↓20.7% | 20↑31.6% | 15↓43.6% | 26 | |
| General & Administrative Expenses | 42↓24.9% | 56↑46.4% | 38↑85.6% | 21↑46.5% | 14 | |
| Selling & Marketing Expenses | -2 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 40↓28.5% | 56↑46.4% | 38↑85.6% | 21↑46.5% | 14 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 49↓30.9% | 72↑23.7% | 58↑63.0% | 36↓12.2% | 40 | |
| Total Costs & Expenses | 64↓22.8% | 83↑20.7% | 69↑53.7% | 45↓7.6% | 48 | |
| Operating Results | ||||||
| Operating Income | -55↑32.4% | -82↓20.3% | -68↓56.0% | -44↑16.8% | -52 | |
| Depreciation & Amortization | 2↓3.4% | 2↑12.3% | 2↑11.1% | 2↑37.2% | 1 | |
| EBITDA | -83↑21.9% | -106↓68.8% | -63↓52.3% | -41↑19.8% | -51 | |
| EBIT | -85↑21.6% | -108↓67.2% | -65↓50.7% | -43↑18.5% | -53 | |
| Interest & Other Income | ||||||
| Net Interest Income | -6↓66.9% | -4↑19.0% | -5↓74.7% | -3↓99.0% | -1 | |
| Interest Income | 2↑19.9% | 1↑272.8% | 0.37↓39.3% | 0.61↓26.6% | 0.84 | |
| Interest Expense | 8↑54.4% | 5↑2.3% | 5↑53.7% | 3↑51.2% | 2 | |
| Non-Operating Income | 29↑12.2% | 26↑876.3% | -3↓377.8% | -0.71↓424.8% | 0.22 | |
| Other Income / Expenses | -38↓19.2% | -31↓1729.3% | -2↑34.1% | -3↓8.2% | -2 | |
| Income Before Tax | -93↑18.1% | -113↓62.4% | -70↓50.9% | -46↑15.7% | -55 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.99 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -93↑18.1% | -113↓62.4% | -70↓50.9% | -46↑17.2% | -56 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -93↑34.1% | -141↓94.0% | -73↓53.6% | -47↑15.3% | -56 | |
| Bottom-Line Net Income | -94↑17.2% | -113↓62.4% | -70↓50.9% | -46↑17.2% | -56 | |
| EPS (Basic) | -5.96↑63.6% | -16.37↓91.5% | -8.55↓31.5% | -6.50↑53.6% | -14.02 | |
| EPS (Diluted) | -5.96↑63.6% | -16.37↓91.5% | -8.55↓31.5% | -6.50↑53.6% | -14.02 | |
| Weighted Average Shares | 16↑80.9% | 9↑1.3% | 8↑16.8% | 7↑82.7% | 4 | |
| Weighted Average Diluted Shares | 16↑80.9% | 9↑1.3% | 8↑16.8% | 7↑82.7% | 4 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.